Barclays Maintains Underweight on Aspen Aerogels, Raises Price Target to $5
Barclays analyst David Anderson maintains Aspen Aerogels (NYSE:ASPN) with a Underweight and raises the price target from $4 to $5.
Stocks · News reference
Aspen Aerogels Sees Q3 GAAP EPS $(0.11)-$(0.07) vs $(0.14) Est; Sees Sales $65.000M-$80.000M vs $56.933M Est
Aspen Aerogels (NYSE:ASPN) is looking for Q3 GAAP EPS of $(0.11)-$(0.07) vs $(0.14) analyst estimate. sees sales of $65.000 million-$80.000 million vs $56.933 million analyst estimate.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Crude Oil Gains 2%; Keurig Dr Pepper Earnings Top Views
Dow drops over 300 points, NASDAQ down 0.05% and S&P 500 down 0.19%. Keurig Dr Pepper reports strong Q2 results. Energy sector up, real estate down.
Motorola Solutions Posts Upbeat Q2 Earnings, Joins Insmed, Diodes, Parker-Hannifin And Other Big Stocks Moving Higher On Thursday
US stocks mixed on Thurs. Dow Jones down 50 pts. Motorola Solutions Inc shares up 9.5% after reporting strong Q2 results & raised guidance.
Aspen Aerogels shares are trading higher after the company reported better-than-expected Q2 sales results and issued Q3 guidance above estimates.